MD, Internal Medicine, University of North Carolina School of Medicine (2002)
Employment:
Associate Professor, Medicine, Jacobs School of Medicine & Biomedical Sciences (2017-present)
Associate Medical Staff, Kaleida Health (2010-present)
Staff Physician, Carroll Hospital Center (2009-present)
Assistant Professor, Medicine, Roswell Park Cancer Institute
Clinical Assistant Professor, Medicine, University at Buffalo, The State University of New York Jacobs School of Medicine & Biomedical Sciences
Research Expertise:
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Chronic myeloid leukemia (CML)
Hematologic Oncology
Myelodysplastic syndrome (MDS)
Myeloproliferative diseases (MPD)
Grants and Sponsored Research:
January 2010 A Phase 1, Dose Escalation, Multicenter Study of Two Subcutaneous Regimens of SGI-110, a DNY Hypomethylating Agent,in Subjects with Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia Role: Principal Investigator
January 2010 Randomized Phase II Study of Epigenetic Priming with Inductin Chemotherapy in Patients with Acute Myeloid Leukemia Role: Principal Investigator
January 2010 Wnt inhibitor methylation mediates upregulated B-catenin signaling in AML. RPCI Role: Co-Investigator
Professional Memberships:
Cancer and Leukemia Group B (Alliance) (2010–present)
American Association for Cancer Research (AACR) (2007–present)
American Society of Hematology (ASH) (2006–present)
American Society of Clinical Oncology (ASCO) (2005–present)
American College of Physicians (ACP) (2003–present)